Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
Marc Suárez‐Calvet, Gernot Kleinberger, Miguel Ángel Araque Caballero, et al.
EMBO Molecular Medicine (2016) Vol. 8, Iss. 5, pp. 466-476
Open Access | Times Cited: 428

Showing 1-25 of 428 citing articles:

The amyloid hypothesis of Alzheimer's disease at 25 years
Dennis J. Selkoe, John Hardy
EMBO Molecular Medicine (2016) Vol. 8, Iss. 6, pp. 595-608
Open Access | Times Cited: 5110
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Marco Colonna, Oleg Butovsky
Annual Review of Immunology (2017) Vol. 35, Iss. 1, pp. 441-468
Open Access | Times Cited: 2059
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Hyuk Sung Kwon, Seong‐Ho Koh
Translational Neurodegeneration (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 1640
Microglia emerge as central players in brain disease
Michael W. Salter, Beth Stevens
Nature Medicine (2017) Vol. 23, Iss. 9, pp. 1018-1027
Closed Access | Times Cited: 1462
Microglia in neurodegeneration
Suzanne E. Hickman, Saef Izzy, Pritha Sen, et al.
Nature Neuroscience (2018) Vol. 21, Iss. 10, pp. 1359-1369
Open Access | Times Cited: 1366
TREM2 — a key player in microglial biology and Alzheimer disease
Tyler K. Ulland, Marco Colonna
Nature Reviews Neurology (2018) Vol. 14, Iss. 11, pp. 667-675
Closed Access | Times Cited: 531
Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease
Estella A. Newcombe, Judith Camats‐Perna, Mallone L. Silva, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 457
Current state of Alzheimer’s fluid biomarkers
José Luís Molinuevo, Scott Ayton, Richard Batrla, et al.
Acta Neuropathologica (2018) Vol. 136, Iss. 6, pp. 821-853
Open Access | Times Cited: 444
The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway
Aleksandra Deczkowska, Assaf Weiner, Ido Amit
Cell (2020) Vol. 181, Iss. 6, pp. 1207-1217
Open Access | Times Cited: 413
An early and late peak in microglial activation in Alzheimer’s disease trajectory
Zhen Fan, David J. Brooks, Aren Okello, et al.
Brain (2017), pp. aww349-aww349
Open Access | Times Cited: 361
TREM2, Microglia, and Neurodegenerative Diseases
Felix L. Yeh, David V. Hansen, Morgan Sheng
Trends in Molecular Medicine (2017) Vol. 23, Iss. 6, pp. 512-533
Closed Access | Times Cited: 358
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
Joana B. Pereira, Shorena Janelidze, Ruben Smith, et al.
Brain (2021) Vol. 144, Iss. 11, pp. 3505-3516
Open Access | Times Cited: 336
TREM2 in Neurodegenerative Diseases
Taylor R. Jay, Victoria E. von Saucken, Gary E. Landreth
Molecular Neurodegeneration (2017) Vol. 12, Iss. 1
Open Access | Times Cited: 333
Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models
C.Y. Daniel Lee, Anthony Daggett, Xiaofeng Gu, et al.
Neuron (2018) Vol. 97, Iss. 5, pp. 1032-1048.e5
Open Access | Times Cited: 328
Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model
Li Zhong, Ying Xu, Rengong Zhuo, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 289
Elucidating the Role of TREM2 in Alzheimer’s Disease
Jason D. Ulrich, Tyler K. Ulland, Marco Colonna, et al.
Neuron (2017) Vol. 94, Iss. 2, pp. 237-248
Open Access | Times Cited: 288
Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapies
Henrik Zetterberg, Barbara B. Bendlin
Molecular Psychiatry (2020) Vol. 26, Iss. 1, pp. 296-308
Open Access | Times Cited: 286
Soluble TREM2 induces inflammatory responses and enhances microglial survival
Li Zhong, Xiao‐Fen Chen, Tingting Wang, et al.
The Journal of Experimental Medicine (2017) Vol. 214, Iss. 3, pp. 597-607
Open Access | Times Cited: 284
The complexity of tau in Alzheimer’s disease
Nima Naseri, Hong Wang, Jennifer D. Guo, et al.
Neuroscience Letters (2019) Vol. 705, pp. 183-194
Open Access | Times Cited: 283
TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury
Fargol Mazaheri, Nicolas Snaidero, Gernot Kleinberger, et al.
EMBO Reports (2017) Vol. 18, Iss. 7, pp. 1186-1198
Open Access | Times Cited: 280
TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer’s Disease
Ana Griciuc, Shaun R. Patel, Anthony Federico, et al.
Neuron (2019) Vol. 103, Iss. 5, pp. 820-835.e7
Open Access | Times Cited: 278
Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
Marc Suárez‐Calvet, Estrella Morenas‐Rodríguez, Gernot Kleinberger, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 264
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Piotr Lewczuk, Peter Riederer, Sid E. O’Bryant, et al.
The World Journal of Biological Psychiatry (2017) Vol. 19, Iss. 4, pp. 244-328
Open Access | Times Cited: 257
Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease
Michael Ewers, Nicolai Franzmeier, Marc Suárez‐Calvet, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 507
Open Access | Times Cited: 251
Page 1 - Next Page

Scroll to top